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Department of Orthodontics and Pediatric Dentistry, School of Dentistry, University of Michigan, Ann Arbor, MI, USA
Hypophosphatasia is a rare heritable disorder caused by inactivating mutations
in the gene (Alpl) that encodes tissue nonspecific alkaline phosphatase (TNAP).
Hypophosphatasia with onset in infants and children can manifest as rickets. How
TNAP deficiency leads to bone hypomineralization is well explained by TNAP’s primary
function of pyrophosphate hydrolysis when expressed in differentiated bone forming
cells. How TNAP deficiency leads to abnormalities within endochondral growth plates
is not yet known. Previous studies in hypophosphatemic mice showed that phosphate
promotes chondrocyte maturation and apoptosis via MAPK signaling. Alpl−/− mice
are not hypophosphatemic but TNAP activity does increase local levels of inorganic
phosphate. Therefore, we hypothesize that TNAP influences endochondral bone
development via MAPK. In support of this premise, here we demonstrate cranial base
bone growth deficiency in Alpl−/− mice, utilize primary rib chondrocytes to show that
TNAP influences chondrocyte maturation, apoptosis, and MAPK signaling in a cell
autonomous manner; and demonstrate that similar chondrocyte signaling and apoptosis
abnormalities are present in the cranial base synchondroses of Alpl−/− mice. Micro
CT studies revealed diminished anterior cranial base bone and total cranial base
lengths in Alpl−/− mice, that were prevented upon injection with mineral-targeted
recombinant TNAP (strensiq). Histomorphometry of the inter-sphenoidal synchondrosis
(cranial base growth plate) demonstrated significant expansion of the hypertrophic
chondrocyte zone in Alpl−/− mice that was minimized upon treatment with recombinant
TNAP. Alpl−/− primary rib chondrocytes exhibited diminished chondrocyte proliferation,
aberrant mRNA expression, diminished hypertrophic chondrocyte apoptosis and
diminished MAPK signaling. Diminished apoptosis and VEGF expression were also
seen in 15 day-old cranial base synchondroses of Alpl−/− mice. MAPK signaling
was significantly diminished in 5 day-old cranial base synchondroses of Alpl−/− mice.
Together, our data suggests that TNAP is essential for the later stages of endochondral
bone development including hypertrophic chondrocyte apoptosis and VEGF mediated
recruitment of blood vessels for replacement of cartilage with bone. These changes
may be mediated by diminished MAPK signaling in TNAP deficient chondrocytes due
to diminished local inorganic phosphate production.
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INTRODUCTION
Hypophosphatasia is a rare heritable disorder caused by
inactivating mutations in the gene (Alpl) that encodes tissue
nonspecific alkaline phosphatase (TNAP). Manifestations of
hypophosphatasia in humans depend upon phenotype severity
and age of onset (Rathbun, 1959; Mornet, 2007; Whyte et al.,
2015). The skeletal presentation of adult onset hypophosphatasia
can include osteomalacia, bone pain, bone fractures and
pseudofractures (Linglart and Biosse-Duplan, 2016; Whyte,
2016). The skeletal presentation of infancy and childhood onset
hypophosphatasia can include rickets, bone pain, bowed bones,
bone fractures, craniosynostosis, and an abnormal craniofacial
shape (Collmann et al., 2009; Linglart and Biosse-Duplan, 2016;
Whyte, 2016).
Alpl−/− mice serve as an important model of
hypophosphatasia. Alpl−/− mice develop long and craniofacial
bone mineralization abnormalities similar to those seen in
human infantile hypophosphatasia (Fedde et al., 1999; Liu
et al., 2014). Furthermore, these mice were previously used to
demonstrate that systemic treatment with a mineral-targeted
recombinant form of TNAP enzyme can minimize long bone
and craniofacial skeletal abnormalities when provided shortly
after birth (Millán et al., 2008; Liu et al., 2015). Alpl−/−
mice are phenotypically normal at birth but quickly develop
skeletal disease including rib, long bone, calvarial, and facial
bone hypomineralization. Histologic evidence of chondrocyte
maturation abnormalities within long bone epiphyseal and
cranial base synchondroses were also reported (Narisawa et al.,
1997; Fedde et al., 1999; Hessle et al., 2002; Liu et al., 2014).
Together, these results indicate that TNAP is essential for both
intramembranous and endochondral bone development.
Previous studies of Alpl−/− mice also revealed important
insights into mechanisms by which TNAP mediates skeletal
development. Tissue nonspecific alkaline phosphatase (TNAP) is
a glycosylphosphatidylinositol anchored ectoenzyme (Low and
Zilversmit, 1980) that is highly expressed in differentiated bone
forming cells (Millán andWhyte, 2016). TNAP activity promotes
tissue mineralization by hydrolyzing inorganic pyrophosphate
(PPi) to inorganic phosphate (Pi) (Fedde et al., 1999), and
by dephosphorylating osteopontin (Narisawa et al., 2013).
PPi and osteopontin are strong inhibitors of mineralization
(Fleisch et al., 1966; Register and Wuthier, 1985; Addison
et al., 2010), and crossing of Alpl−/− mice with Enpp1−/−
and/or Opn−/− knockout mice partially rescues the Alpl−/−
hypomineralization phenotype (Harmey et al., 2004, 2006;
Anderson et al., 2005). It is therefore currently accepted that the
bone hypomineralization phenotype of hypophosphatasia results
largely from the accumulation of these two inhibitors, albeit in a
bone site specific manner (Anderson et al., 2005).
Notably, previously reported evidence also indicates that
TNAP has important functions in pre-differentiated and
differentiating cells that are distinct from and in addition to
its function of promoting tissue mineralization when expressed
in differentiated cells. TNAP is expressed in neural progenitor
cells before and after birth (Langer et al., 2007; Kermer et al.,
2010), and in cranial bone rudiments days prior to the onset of
matrix mineralization (Ishii et al., 2003; Sun et al., 2013). TNAP
influences neural progenitor cell proliferation, differentiation
and migration; and TNAP deficiency causes altered neuronal
morphology and activity (Kermer et al., 2010; Sebastián-Serrano
et al., 2016). TNAP also appears to directly influence the
proliferation and differentiation of cranial bone progenitor cells
and TNAP deficiency causes craniosynostosis (Liu et al., 2014,
2015). Of relevance to the studies reported here, TNAP is
also strongly expressed in growth plate chondrocytes (Fedde
et al., 1999). TNAP deficiency causes endochondral growth plate
abnormalities, yet the mechanism by which TNAP deficiency
alters chondrocyte maturation and the process of endochondral
bone development is not yet known.
We previously showed that Alpl−/− mice exhibit craniofacial
shape abnormalities indicative of possible cranial base growth
deficiency, and noted histologic abnormalities within cranial base
synchondroses of juvenileAlpl−/− mice (Liu et al., 2014). Cranial
base synchondroses are bidirectional growth plates with a central
resting chondrocyte zone surrounded bilaterally by proliferative
and hypertrophic chondrocyte zones (Nie, 2005;Wei et al., 2016).
Similar to that seen in long bones, cranial base bones elongate
via an endochondral process involving chondrocyte proliferation,
hypertrophy and apoptosis followed by vascular invasion and
replacement of cartilage with bone. Previous studies showed that
inorganic phosphate levels control chondrocyte maturation and
apoptosis via MAPK signaling (Kimata et al., 2010; Miedlich
et al., 2010). Alpl−/− mice are not hypophosphatemic yet TNAP
is a local generator of inorganic phosphate. Because the growth
plate abnormalities of Alpl−/− mice appear similar to those of
systemically hypophosphatemic mice (Li et al., 1997; Sabbagh
et al., 2005), we hypothesize that TNAP directly influences
cranial base chondrocyte maturation via a similar phosphate
mediated process. In support of this idea, here we demonstrate
cranial base bone growth deficiency in Alpl−/− mice, utilize
primary rib chondral chondrocytes to show that TNAP influences
chondrocyte maturation, apoptosis, andMAPK signaling in a cell
autonomous manner; and demonstrate that similar chondrocyte
signaling and maturation abnormalities are present in the cranial
base synchondroses of Alpl−/− mice.
MATERIALS AND METHODS
Animals
Alpl+/− (TNAP+/−) mice were bred and genotyped to generate
Alpl+/+ and Alpl−/−mice, as previously reported (Narisawa
et al., 1997; Yadav et al., 2011; Liu et al., 2014). TNAP is essential
for vitamin B6 metabolism (Waymire et al., 1995). Therefore, all
mice were given free access to modified laboratory rodent diet
5,001 containing 325 ppm of pyridoxine to prevent seizures and
improve health. All animal procedures were performed according
to federal guidelines for the care and use of animals in research
and/or the University of Michigan’s University Committee on
Use and Care of Animals.
TNAP Enzyme Treatment
Recombinant TNAP protein (strensiq, previously known as
asfotase-alfa) is composed of soluble human TNAP enzyme fused
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to the constant region of human IgG1 (Fc), and a C-terminal
deca-aspartate region that confers targeting to hydroxyapatite
(Nishioka et al., 2006; Whyte et al., 2012). Mice were injected
subcutaneously in the subscapular region, daily, with vehicle or
8.2mg/kg of protein starting at birth. This dose and regimen was
previously shown to prevent long bone, rib, vertebral and tooth
defects in murine HPP (Millán et al., 2008; McKee et al., 2011;
Yadav et al., 2011; Foster et al., 2013). This protocol was also
previously shown to improve cranial bone mineralization and
prevent craniosynostosis in Alpl−/−mice (Liu et al., 2015).
Scanning Electron Microscropy
Cranial base bones were gold coated (DESK II, Denton Vacuum)
then imaged using a scanning electron microscope (JSM-
7800FLV Scanning Electron Microscope, JEOL USA Inc.) with a
back-scattered electron (BSE) detector and an energy-dispersive
X-ray spectrometer (EDX) for quantification of carbon, calcium,
and phosphate content in bone tissues using AZtecEnergy
software (Oxford Instruments).
Micro Computed Tomography
Whole dissected skulls were scanned at an 18µm isotropic
voxel resolution using the eXplore Locus SP micro-computed
tomography imaging system (GE Healthcare Pre-Clinical
Imaging, London, ON, Canada), as previously described (Liu
et al., 2013, 2014). Linear distances between cranial base
landmarks at the midline were generated using Dolphin Imaging
11.0 software (Dolphin Imaging and Management Solutions,
Chatsworth, CA). Linear distances included presphenoid length
(distance between the most anterior aspect of the presphenoid
bone and the most posterior aspect of the presphenoid bone),
basisphenoid length (distance between the most anterior aspect
of the basisphenoid bone and the most posterior aspect of the
basisphenoid bone), basioccipitus length (distance between
the most anterior aspect of the basioccipital bone and the
most posterior aspect of the basioccipital bone), total cranial
base length (distance between the most anterior aspect of
the presphenoid bone and the most posterior aspect of the
basisphenoid bone) and total skull length (distance between
nasale and opisthion). No significant difference between genders
was found; therefore, genders were combined for analyses
(n = 24 per genotype and treatment group).
Histology and Histomorphometry
For qualitative histologic assessment, mouse skulls were fixed,
decalcified, and embedded in paraffin. Paraffin tissue blocks were
trimmed in the sagittal plane to within 4mm of the skull midline.
Eight micrometer sections parallel to the cranial base were
prepared using a Leica RM2255 microtome (Leica Microsystems
Inc., Buffalo Groves, IL).
For histomorphometry of cranial base synchondroses prior
to the onset of craniosynostosis, 15 day-old mouse skulls were
fixed, serially dehydrated, washed in isopropanol, incubated in
xylene and then embedded in methyl methacrylate. Methacrylate
blocks were trimmed in the sagittal plane to within 2mm of the
skull midline. Four micrometer sagittal sections of the cranial
base were transferred to slides and dried overnight. Stained slides
were photographed at a 10x magnification. Hypertrophic zone
width and total synchondrosis widths were calculated using NIH
Image software. Cell and synchondrosis widths were performed
in triplicate and an average value for each mouse was utilized
to calculate means and standard deviations per genotype and
treatment group (n = 24 Alpl−/− untreated mice, 8 strensiq
treated Alpl−/−mice, 8 Alpl+/+ mice).
Primary Chondrocyte Isolation
Because isolation of chondrocytes from murine cranial base
yielded very few cells per mouse, primary rib chondrocytes
were isolated from 5 day-old pups by sequential enzyme
digestion to investigate a potential cell autonomous influence
of TNAP on chondrocytes. Costal cartilage was isolated and
digested in 2mg/ml pronase (Sigma) at 37C for 1 h with gentle
agitation. After washing with PBS, the cartilage segments were
digested in 3mg/ml collagenase D at 37C for 1 h followed by
a final digestion in fresh collagenase D for 5 h. Cells were
then filtered through a cell strainer and centrifuged at 400
g for 5min. Cells were immediately counted and plated for
experiments.
Cell Culture and Assay
Cells were cultured in DMEM F12 media containing
10% fetal bovine serum and 1% penicillin/streptomycin.
Cells were differentiated in DMEM F12 media containing
10% fetal bovine serum, 1% penicillin/streptomycin, 1x
insulin/transferrin/selenium supplement, 50 ug/ml ascorbate
and 5mM NaPO4. Alkaline phosphatase enzyme activity was
assayed using the colorimetric substrate, NBT/ BCIP (Sigma).
For Alcian Blue staining, cells were washed with phosphate
buffered saline and fixed with 10% formalin. The cells were
then stained with a 1% Alcian Blue solution (1% alcian blue
in 60% ethanol/40% acetic acid). After destaining in 60%
ethanol/40% acetic acid, cells were photographed and wells
were scanned. Scans were quantified by densitometry using
NIH Image software. To assay cellular proliferation, cells were
seeded and grown DMEM F12 media containing 10% fetal
bovine serum and 1% penicillin/streptomycin. Cells were plated
at equivalent numbers, grown under equivalent conditions,
monolayer cells were washed to removed dead cells, cells were
trypsinized then stained with trypan blue, and then counted
in triplicate for each time point using a hemocytometer. To
assay cellular apoptosis, a Cell Death Detection kit (Roche)
was utilized according to the manufacturer’s instructions. This
assay uses antibodies directed against DNA and histones, to
quantify mono- and oligonucleosomes that are released into
the cytoplasm of cells that die from apoptosis. Briefly, 10,000
cells were seeded into 96-well plates and grown in media
containing 10 or 0.5% FBS for 48 h. Cell lysate was utilized to
quantify apoptosis by a colorimetric reaction and absorbance was
measured at 405 nm (reference wavelength of 490 nm). For RNA
analysis, RNA was isolated using Trizol reagent (Invitrogen)
following manufacturer protocols. mRNA levels were assayed
by reverse transcription and real time PCR. Real time PCR
was performed utilizing the murine bActin primer/probe
set 4352933E, the Sox9 primer/probe set Mm00448840_m1,
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the Col2a1 primer/probe set Mm01309565_m1, the Col10a1
primer/probe set Mm00487041_m1, the Runx2 primer/probe set
Mm00501578_m1, the Alpl primer/probe set Mm00475834_m1,
the VEGF primer/probe set Mm00437306_m1, and Taqman
Universal PCR Master Mix (Applied Biosystems). Real-
time PCR was performed on a ViiA7 thermocyler (Life
Technologies) and quantified by comparison to a standard
curve.
Immunoblotting
Preparation of cell lysate was achieved by solubilization in
RIPA buffer (50mM Tris-Cl pH 7.4, 150mM NaCl, 1%
NaDeoxycholate, 1% Triton-X 100, 0.1% SDS) containing 1x
protease inhibitor cocktail (Sigma), followed by removal of
insoluble material by centrifugation at 12,000 rpm for 10min.
Prior to loading, 5x Laemmli loading buffer was added to
a final 1x concentration, samples were boiled for 3min, and
then iced. Samples were separated by SDS polyacrylamide gel
electrophoresis and transferred onto Immobilon (Millipore).
Immunoreactive protein bands were visualized by incubation
with MAPK and phospho-MAPK antibodies (Cell Signaling),
HRP conjugated secondary antibody (Abcam) and enhanced
chemiluminescence (Pierce).
Immunofluorescence
Skulls of 15 day-old mice were fixed and paraffin embedded.
Fresh 7µm sagittal setions of the cranial base were
immunostained using Annexin V antibody (Abcam), anti
VEGF antibody (Abcam), or cleaved caspase 3 antibody (Cell
Signaling). After primary antibody incubation, sections were
incubated with Alexafluor 555 goat anti-rabbit IgG (Molecular
Probes), then mounted in ProLong Gold antifade reagent
with DAPI (Invitrogen). Images were captured using Nikon
Eclipse E800 microscope. Image J software was used for
immunofluorescent stain quantification to calculate means
and standard deviations per genotype (n = 3 mice per
genotype).
Immunohistochemistry
Skulls of 5 day-old mice were fixed and paraffin embedded. Fresh
8µm sagittal sections of the cranial base were immunostained
using MAPK, and phosphorylated-MAPK primary antibodies
(Cell Signaling), HRP-conjugated anti-rabbit secondary antibody
(Abcam), an antigen unmasking solution (Vector Labs) and 3,3’-
diaminobenzidine (DAB) colorimetric detection (Abcam). The
number of brown stained cells and the number of total cells
present within the synchondroses were counted. Three sections
per mouse were calculated and an average value per mouse was
utilized to calculate means and standard deviations per genotype
(n = 3 mice per genotype).
Statistical Analysis
All quantified data are presented as means +/− standard
deviations. For quantifiable data, statistical significance between
genotypes and treatment groups was established using the
student’s t-test. A p < 0.05 is considered as significant.
RESULTS
TNAP Deficiency Causes Cranial Base
Abnormalities in Alpl−/− Mice
Similar to that which we previously reported (Liu et al.,
2014), H&E staining of the cranial base demonstrated
gross abnormalities of both the sphenooccipital (SOS)
and intersphenoidal (ISS) synchondroses in Alpl−/− mice
(Supplementary Figure 1). Both growth plates appeared
widened, and conspicuous expansion of hypertrophic
chondrocyte zones was evident. Also of note were the excess
cortical and trabecular bone matrix deposition, and loss of
marrow space in Alpl−/− cranial base bones.
Scanning electron microscopy (SEM) with backscattered
electron detection (BSE) of cranial base bones from 20 day-
old mice revealed mineralization within both the ISS and SOS
growth plates, and within the presumedmarrow space ofAlpl−/−
mice (Figure 1). In cranial base trabecular bone surrounding
both the ISS and SOS, energy dispersive X-ray spectroscopy
(EDX) demonstrated increased calcium and phosphate content
inAlpl−/−mice, as compared to that seen in cranial base bones of
wild type mice (Table 1). Calcium/phosphate ratios were similar
in Alpl−/− and Alpl+/+ mice, indicating that the higher mineral
content seen in the trabecular bone of Alpl−/− mice was likely
apatitic. Alpl−/− cortical bone located immediately adjacent to
the presumed marrow cavity had similar calcium and phosphate
contents plus a similar calcium/phosphate ratio to that ofAlpl+/+
cortical bone. In contrast, Alpl−/− cortical bone located farther
away from the presumed marrow space had diminished calcium
and phosphate content, and a similar calcium/phosphate ratio to
that of Alpl+/+ cortical bone. Alpl−/− cortical bone was assessed
in two regions while Alpl+/+ cortical bone was assessed in only
one region, because cortical bone thickening was only present in
cranial base cortical bone of Alpl−/− mice.
Recombinant TNAP Enzyme Therapy
Rescues Cranial Base Defects in Alpl−/−
Mice
We previously showed that post-natal treatment with a mineral
targeted recombinant form of TNAP enzyme (Strensiq) prevents
craniofacial skeletal shape abnormalities in these mice (Liu
et al., 2015). To determine if recombinant TNAP enzyme
replacement therapy influences the cranial base in Alpl−/− mice,
here we quantified changes in cranial base bone lengths, to
verify consistency of cranial base growth abnormalities and
efficacy of TNAP enzyme replacement for rescuing cranial base
bones in Alpl−/− mice. Results showed that while basioccipital
cranial base bones were not different between genotypes,
the basisphenoid and presphenoid cranial base bones were
significantly shorter in vehicle treated Alpl−/− mice as compared
to Alpl+/+ mice (Figure 2). Total length of the cranial base and
total skull length were also significantly shorter in vehicle treated
Alpl−/− mice as compared to Alpl+/+ mice. Treatment with
8.2mg/kg/day of recombinant TNAP enzyme increased apparent
length of the basisphenoid and presphenoid bones, although
not to the extent of that seen in Alpl+/+ mice. Importantly,
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FIGURE 1 | Backscattered electron detection reveals mineralization differences in the cranial base of 20 day-old Alpl −/− and Alpl+/+ mice. Cranial
base bones surrounding the sphenoccipital (A,B) and intersphenoid (C,D) synchondroses are shown. Mineral is present within the presumed marrow space and
within the cartilaginous growth plates of cranial bones isolated from Alpl−/− (B,C) but not Alpl+/+ (A,B) mice. Cortical bone matrix that is farther away from the
presumed marrow space (cortical-2) appears less mineralized than cortical bone matrix that is closer to the presumed marrow space (cortical-1) in Alpl−/− mice.
TABLE 1 | Energy dispersive X-ray Spectroscopy.
Genotype Region Bone Carbon (percent by weight) Calcium (percent by weight) Phosphate (percent by weight) Calcium/ phosphate ratio
Alpl+/+ SOS Trabecular 28.7 ± 2.6 48.6 ± 1.9 23.3 ± 0.8 2.1 ± 0.0
Alpl−/− SOS Trabecular 22.3 ± 1.1a 52.6 ± 1.0a 25.1 ± 0.6a 2.1 ± 0.1
Alpl+/+ ISS Trabecular 30.8 ± 5.3 46.9 ± 3.6 22.3 ± 1.7 2.1 ± 0.0
Alpl−/− ISS Trabecular 18.7 ± 2.6a 55.4 ± 1.9a 25.9 ± 0.8a 2.1 ± 0.0
Alpl+/+ SOS Cortical 31.1 ± 3.9 46.6 ± 2.5 22.3 ± 1.5 2.1 ± 0.0
Alpl−/− SOS Cortical–1 44.6 ± 9.4a 38.5 ± 6.3a 16.9 ± 3.3a 2.3 ± 0.2
Alpl−/− SOS Cortical–2 56.8 ± 5.8a 29.4 ± 3.6a 13.9 ± 2.2a 2.1 ± 0.1
Alpl+/+ ISS Cortical 33.2 ± 4.1 45.5 ± 2.7 21.2 ± 1.4 2.2 ± 0.0
Alpl−/− ISS Cortical–1 33.0 ± 12.0 46.1 ± 7.9 20.1 ± 4.1 2.2 ± 0.1
Alpl−/− ISS Cortical–2 51.2 ± 2.5a 32.9 ± 1.4a 15.8 ± 1.1a 2.1 ± 0.1
a Indicates statistical significance between genotypes.
treatment with mineral-targeted TNAP enzyme increased total
cranial base length similar to that seen in Alpl+/+ mice. As
previously reported, total skull length was also rescued upon
treatment with recombinant TNAP (Liu et al., 2015). These
results demonstrate that TNAP mediates anterior cranial base
bone growth.
Because micro CT analysis only allows for quantification
of mineralized tissues, we also performed histomorphometry
on cranial base growth plates. We focused on analysis of the
inter-sphenoidal synchondrosis because the micro CT based
assessment of cranial base bone lengths indicated that anterior
cranial base bones were more affected by genotype and treatment
than posterior cranial base bones. Results showed that the
intersphenoidal synchondrosis was wider in untreated Alpl−/−
mice by approximately 2 weeks after birth, and that treatment
with recombinant TNAP enzyme partially normalized this
phenotype (Figure 3). Width of the hypertrophic chondrocyte
zone was on average more than 3x greater in untreated Alpl−/−
mice when compared to Alpl+/+ mice. Treatment significantly
decreased width of the hypertrophic zone in Alpl−/− mice,
although this zone was still expanded compared to that seen
in Alpl+/+ mice. Finally, the ratio of hypertrophic zone width
to total width of the intersphenoidal synchondrosis was larger
in untreated Alpl−/− mice compared to Alpl+/+ mice. In
Frontiers in Physiology | www.frontiersin.org 5 March 2017 | Volume 8 | Article 161
Nam et al. TNAP Regulates Synchondrosis Development
FIGURE 2 | Rescue of cranial base bone lengths by treatment with mineral-targeted recombinant TNAP enzyme in Alpl−/− mice. Anterior-posterior bone
lengths of cranial base bones taken at the midline from micro CT scans of 15 day-old untreated Alpl−/− (white bars), 8.2mg/kg/day treated Alpl−/− (striped bars), and
Alpl+/+ (black bars) mouse skulls are shown. Length of the intersphenoid bone, total cranial base length and total skull length are diminished in untreated Alpl−/−mice
when compared to treated Alpl−/− or Alpl+/+ mice. ap < 0.05 significant difference between genotypes. bp < 0.05 significant difference between treatment groups.
FIGURE 3 | Rescue of hypertrophic zone expansion by treatment with mineral-targeted recombinant TNAP enzyme in Alpl−/− mice. ISS hypertrophic
zone widths and total ISS widths of 15 day-old untreated Alpl−/− (white bars), 8.2mg/kg/day treated Alpl−/− (striped bars), and Alpl+/+ (black bars) were measured.
The hypertrophic zone width and hypertrophic zone width per total ISS width are increased in untreated Alpl−/−mice, when compared to treated Alpl−/− or Alpl+/+
mice. ap < 0.05 significant difference between genotypes. bp < 0.05 significant difference between treatment groups.
contrast, the ratio of hypertrophic zone width to total width
of the intersphenoidal synchondrosis was not larger in treated
Alpl−/− mice, when compared to Alpl+/+ mice. These results
demonstrate that TNAP mediates cranial base growth plate
maturation and that post-natal treatment with mineral-targeted
TNAP enzyme is efficacious for minimizing cranial base growth
plate abnormalities in Alpl−/− mice.
TNAP Deficiency Directly Influences
Primary Chondrocyte Behavior
To initiate an investigation into mechanisms by which TNAP
deficiency causes growth plate abnormalities and determine if
TNAP influences chondrocytes in a cell autonomous manner,
we next isolated primary rib chondral chondrocytes from
Alpl−/− and Alpl+/+ mice. Alkaline phosphatase staining
confirmed significantly diminished alkaline phosphatase activity
in chondrocytes isolated from Alpl−/− mice (Figures 4A,B).
Accumulation of proteoglycans as assessed by staining with
Alcian Blue was increased in Alpl−/− chondrocytes, when
compared toAlpl+/+ chondrocytes (Figures 4C,D). Proliferation
of chondrocytes isolated from Alpl−/− mice was diminished
when compared to cells isolated from Alpl+/+ mice (Figure 4E).
We also performed real time PCR analysis of gene expression
of Alpl−/− and Alpl+/+ chondrocytes undergoing differentiation
in vitro, to further investigate the influence of TNAP on
chondrocyte differentiation (Figure 5). As expected, results
showed minimal TNAP mRNA expression at all time points
in cells isolated from Alpl−/− mice. Sox9 mRNA expression
levels were high early and then decreased at later time points
of chondrocyte differentiation in Alpl+/+ primary chondrocytes.
Sox9 mRNA levels were significantly lower in Alpl−/− as
compared to Alpl+/+ cells at all time points. Aggrecan mRNA
expression levels were high early and then decreased at later
time points of chondrocyte differentiation in Alpl+/+ primary
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FIGURE 4 | Alpl−/− primary chondrocytes exhibit increased proteoglycan accumulation and diminished proliferation. (A,B) Primary rib chondrocytes
isolated from Alpl+/+ and Alpl−/− mice were cultured with or without ascorbate to induce chondrocyte differentiation. TNAP enzyme activity was visualized by
incubation of cells with a colorimetric substrate and quantified by densitometry. (C,D) Primary chondrocytes were cultured under chondrocyte differentiation
conditions for 15 days then stained with Alcian Blue. Staining was quantified by densitometry. (E) Cells were stained with trypan blue and counted at indicated time
points after plating to assay for proliferation (black line = Alpl+/+; gray line = Alpl−/− ). *p < 0.05 between genotypes.
chondrocytes. Aggrecan mRNA levels were significantly lower
in Alpl−/− as compared to Alpl+/+ cells at days 3 and 7
of differentiation. Col2a1 mRNA expression levels were high
early and then decreased at later time points of chondrocyte
differentiation in Alpl+/+ primary chondrocytes. Col2a1 mRNA
levels were significantly lower at day 3 and significantly
higher at days 7 and 15 in Alpl−/− cells, as compared to
Alpl+/+ cells. Runx2 mRNA mRNA expression levels increased
over the time course of differentiation in Alpl+/+ primary
chondrocytes. Runx2 mRNA levels were significantly lower in
Alpl−/− as compared to Alpl+/+ cells at all time points. Col10a1
mRNA expression levels peaked at day 15 of differentiation
in Alpl+/+ primary chondrocytes. Col10a1 mRNA levels were
significantly higher in Alpl−/− as compared to Alpl+/+ cells at
day 15.
TNAP Deficiency Diminishes Chondrocyte
Apoptosis
Hypertrophic chondrocyte apoptosis is an essential component
of endochondral bone growth, and diminished apoptosis could
explain the hypertrophic zone expansion seen in Alpl−/− mice.
We performed in vitro assays on rib chondral chondrocytes
and in vivo assays on cranial base tissues to determine if
apoptosis was diminished in the synchodroses of Alpl−/− mice.
In vitro assays revealed no significant differences in apoptosis
of chondrocytes isolated from Alpl−/− mice as compared to
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FIGURE 5 | Alpl−/− primary chondrocytes exhibit abnormal gene expression during differentiation. (A–F) Primary rib chondrocytes isolated from Alpl+/+
and Alpl−/− mice were cultured to induce chondrocyte differentiation. Experiments were performed in triplicate. RNA was isolated at indicated time points. TNAP,
sox9, aggrecan, Col2a1, Runx2, and Col10a1 mRNA levels were measured by real time PCR. Results are presented as normalized to β-Actin. Solid lines = Alpl+/+
cells, dashed lines = Alpl−/− cells. *p < 0.05 between genotypes.
Alpl+/+ mice before differentiation, but significantly decreased
apoptosis of chondrocytes isolated from Alpl−/− mice after
differentiation into hypertrophic chondrocytes (Figure 6A).
Immunofluorescent staining for Annexin V and caspase 3
markers of apoptosis also revealed significantly diminished
apoptosis of growth plate chondrocytes in both the ISS and
SOS cranial base synchondroses of 15 day old Alpl−/− mice
(Figures 6B–K).
TNAP Deficiency Diminishes Chondrocyte
VEGF Expression
During endochondral bone growth, hypertrophic chondrocytes
secrete VEGF which stimulates vascular ingrowth ultimately
leading to replacement of cartilage with bone, and inhibition
of VEGF signaling causes hypertrophic chondrocyte zone
expansion with diminished bone growth (Gerber et al., 1999;
Carlevaro et al., 2000). Therefore, we next sought to determine
if VEGF expression was diminished in cells and tissues of
Alpl−/− mice. VEGF mRNA levels were significantly lower
in Alpl−/− as compared to Alpl+/+ rib primary chondrocytes
at all time points, and appeared to plateau in Alpl−/− cells,
as oppose to the increase in VEGF expression seen in in
Alpl+/+ cells at later differentiation time points (Figure 7A).
VEGF expression was also significantly diminished within
the hypertrophic chondrocyte zones of Alpl−/− cranial base
synchondroses at 15 days after birth (Figures 7B–F).
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FIGURE 6 | Diminished apoptosis of Alpl−/− hypertrophic chondrocytes. (A) Undifferentiated rib chondrocytes and differentiated rib hypertrophic
chondrocytes from Alpl+/+ and Alpl−/− mice were cultured in media containing 10% FBS. Generation of apoptotic changes in DNA was assayed by a colorimetric
reaction. Results show no difference in the tendency for pre-differentiated cells to undergo apoptosis and a significantly diminished tendency for differentiated
hypertrophic chondrocytes to undergo apoptosis. (B-K) ISS and SOS cranial base tissues were stained for Annexin V and cleaved Caspase 3 markers of apoptosis
by immunofluorescence. Images show diminished expression of Annexin V in Alpl−/− (E,G) compared to Alpl+/+ (D,F) ISS, and diminished expression of cleaved
Caspase 3 in Alpl−/− (I,K) compared to Alpl+/+ (H,J) ISS. Quantification of immunofluorescent stains within the synchondroses from sections of three mice per
genotype demonstrates significant differences in Annexin V (B) and cleaved Caspase 3 (C) expression in the ISS and SOS of Alpl−/− when compared to Alpl+/mice.
*p < 0.05 between genotypes. (HZ hypertrophic chondrocyte zone)
MAPK Activity is Diminished in Cranial
Base Synchondroses of Alpl−/− Mice
Because diminished MAPK signaling mediates the hypertrophic
chondrocyte zone expansion seen in hypophosphatemic mice
(Miedlich et al., 2010), we next sought to determine if MAPK
signaling was decreased in chondrocytes isolated from Alpl−/−
mice. Consistent with previously published results, MAPK
phosphorylation was induced by treatment of rib primary
chondrocytes with inorganic phosphate (Figure 8). Notably, both
basal and Pi induced levels of phosphorylated MAPK protein
were reduced in cells isolated fromAlpl−/− mice when compared
to cells isolated from Alpl+/+ mice. To determine if MAPK
signaling was diminished in cranial base growth plate tissues
of Alpl−/− mice prior to the onset of obvious chondrocyte
abnormalities, we next used immunohistochemistry to quantify
levels of total and activated MAPK protein in ISS and SOS
cranial base tissues of 5 day-old mice. Results showed that while
total MAPK levels were similar in the synchondroses of Alpl−/−
and Alpl+/+ mice, phospho-MAPK levels were significantly
lower in the synchondroses of Alpl−/− mice, as compared
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FIGURE 7 | Diminished VEGF expression in Alpl−/− chondrocytes. (A) Primary rib chondrocytes isolated from Alpl+/+ and Alpl−/− mice were cultured to
induce chondrocyte differentiation and RNA was isolated at indicated time points. VEGF mRNA levels were measured by real time PCR. Results are presented as
normalized to β-Actin. Solid lines = Alpl+/+ cells, dashed lines = Alpl−/− cells. *p < 0.05 between genotypes. (B-F) ISS and SOS cranial base tissues were stained
for VEGF by immunofluorescence. Images show diminished VEGF expression in the ISS of Alpl−/− (C,E) as compared to Alpl+/+ (B,D) mice. (F) Quantification of
immunofluorescent stain within the synchondroses from sections of three mice per genotype demonstrates significant differences in VEGF expression in the ISS and
SOS of Alpl−/− when compared to Alpl+/mice. *p < 0.05 between genotypes. (HZ hypertrophic chondrocyte zone)
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FIGURE 8 | MAPK signaling is diminished in Alpl−/− chondrocytes. Cell
lysate was isolated from primary rib chondrocytes of Alpl−/− and Alpl+/+
mice after culture with/without inorganic phosphate. MAPK activity was
assessed by immunoblotting for phosphorylated and total MAPK protein.
Results show diminished basal and phosphate induced levels of
phosphorylated MAPK protein in lysate of Alpl−/− cells.
to Alpl+/+ mice (Figure 9). More specifically, phospho-MAPK
levels appeared diminished in the perichondrium, in less
differentiated chondrocytes and in hypertrophic chondrocytes of
Alpl−/− mice.
DISCUSSION
TNAP functions to promote bone mineralization in humans and
mice (Millán and Whyte, 2016; Whyte, 2016). Consistent with
this known role of TNAP, Alpl−/− cranial base cortical bone
exhibits location dependent reductions in calcium phosphate
mineral content. Yet excess mineral is present within the
presumed marrow space of Alpl−/− cranial base bones by 2
weeks after birth, as shown in SEM images and as measured
by energy dispersive X-ray spectroscopy. This data is consistent
with reports showing that hypophosphatasia patients can develop
myelophthisic anemia (Millan, 2006; Mornet, 2007). The calcium
to phosphate ratios of Alpl−/− bone tissues are similar to
those of control hydroxyapatite and bone tissues of Alpl+/+
mice, indicating that the mineral within Alpl−/− marrow
is apatitic. SEM images also show evidence of calcification
within the intersphenoidal and sphenoccipital synchondroses
of Alpl−/− but not Alp+/+ mice at 21 days after birth. This
mineral appears within the center of the synchondroses, in
less mature chondrocytes. Mineral deposition normally occurs
during cranial base growth but is more typically seen near the
adjacent bone margins extending into the synchondrosis (Pan
et al., 2013; Vora et al., 2016). That TNAP deficiency causes
cortical hypomineralization but trabecular hypermineralization,
plus ectopic calcification within synchondroses is of interest. It is
possible that the higher mineral deposition in Alpl−/− trabecular
bone occurs as a compensatory response to the lower mineral
deposition seen in Alpl−/− cortical bone, as has been suggested
for the localized regions of long bone hypermineralization that
are found in children with HPP (Girschick et al., 1999, 2007).
It is also possible that TNAP deficiency causes ectopic mineral
deposition by less mature cells through an as yet unknown
process.
Similar to that seen in long bones, cranial base bones elongate
via an endochondral process involving chondrocyte proliferation,
hypertrophy, apoptosis, and replacement of cartilage with
bone (Wei et al., 2016). Alpl−/− mice exhibit hypertrophic
chondrocyte zone expansion in cranial base growth plates plus
diminished cranial base bone growth that is rescued upon
treatment with recombinant TNAP enzyme. This data provides
strong evidence that TNAP mediates the cellular process of
endochondral bone development and is essential for cranial
base growth. These results further support the idea that TNAP
plays multiple important functions during skeletal development
that are in addition to its previously established role in
tissue mineralization. The findings reported here also support
the idea that the overall skull shape abnormalities including
midface deficiency seen in Alpl−/− mice prior to the onset of
craniosynostosis (Liu et al., 2014) result at least in part from
deficient growth of the cranial base.
Cranial base growth plate expansion and increased
hypertrophic zone widths of Alpl−/− mice could result
from increased proliferation and differentiation of chondrocytes,
and/or diminished apoptosis or removal of hypertrophic
chondrocytes. To distinguish between these possibilities,
and to establish that TNAP influences chondrocytes in a
cell autonomous manner, we isolated primary cells from
Alpl−/− mice and wild type littermates. For these studies,
we used rib chondral cells due to the challenges of obtaining
sufficient cell numbers from the cranial base. Alpl−/− primary
chondrocytes displayed diminished proliferation when compared
to cells isolated from wild type mice, indicating that increased
proliferation was not likely the cause of growth plate expansion
seen in Alpl−/− mice. In addition, while Alpl−/− primary
chondrocytes displayed a slightly increased tendency for
proteoglycan accumulation upon differentiation in culture
as assessed by alcian blue staining, a time course of mRNA
expression levels did not reveal a consistent pattern of enhanced
chondrocyte differentiation. Sox9 is known to stimulate Col2a1
and proteoglycan expression, while suppressing Col10a1
expression in less mature chondrocytes (Leung et al., 2011).
Consistent with these known functions of Sox9, Col2a1, and
aggrecan mRNA levels were significantly lower in Alpl−/− cells
as compared to Alpl+/+ cells at day 3 of differentiation. Yet,
despite the lower levels of Sox9 at later differentiation time
points, Col2a1 levels were higher in Alpl−/− than Alpl+/+ cells
at days 7 and 15, indicating that factors other than Sox9 may
be driving the higher Col2a1 gene expression at days 7 and 15
in Alpl−/− cells. Sox5 and Sox6 act cooperatively with Sox9 in
promotion of Col2a1 expression so could mediate the higher
Col2a1 gene expression seen in differentiating Alpl−/− cells
(Lefebvre et al., 1998). But Sox9, Sox5, and Sox6 are known
to stimulate the differentiation of mesenchymal precursors
into proliferating chondrocytes but inhibit maturation into
hypertrophic chondrocytes. Given that Alpl−/− mice exhibit
an expanded hypertrophic chondrocyte zone, it therefore
seems unlikely that Sox9, Sox5, or Sox6 are likely to be driving
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FIGURE 9 | MAPK signaling is diminished in Alpl−/− cranial base synchondroses. Sagittal sections of cranial base synchondroses from 5 day-old mice were
stained for total MAPK and phosphorylated MAPK protein. Total MAPK protein levels appear similar in the SOS and ISS of Alpl+/+ (A,E) and Alpl−/− (B,F) mice.
Phosphoryated MAPK protein levels appear diminished in the SOS and ISS of Alpl−/− (D,H), as compared to Alpl+/+ (C,G) mice. Stains were quantified by brown
stained cell counting, and normalized to the total cell count. (I,J) Quantification of results from three mice per genotype demonstrates consistent and significantly
diminished levels of phosphoryated MAPK in both the SOS and ISS of Alpl−/− mice. *p < 0.05 between genotypes. H, hypertrophic zone; PH, prehypertrophic zone;
PC, perichondrium; R, resting zone.
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the Alpl−/− growth plate phenotype. It is also worth noting
that differentiation of rib chondral cells in vitro may not
entirely reflect differentiation of cranial base chondrocytes
in vivo.
We next investigated altered cell death as a potential
mechanism underlying the abnormal endochondral bone
development seen in Alpl−/− mice, and found that Alpl−/−
primary hypertrophic chondrocytes exhibited a diminished
tendency for apoptosis in vitro. Consistent with this finding,
annexin V and fragmented caspase 3 expression were lower
in Alpl−/− than in Alpl+/+ cranial base synchondroses at 15
days after birth, indicating that Alpl−/− chondrocytes have a
diminished tendency to undergo apoptosis. This phenomenon
could account for the expanded hypertrophic chondrocyte
zone seen in Alpl−/− growth plates. Hypertrophic chondrocyte
apoptosis coincides with blood vessel invasion leading to
clastic removal of cartilaginous matrix and replacement with
bone that is dependent upon expression of VEGF (Gerber
et al., 1999; Kronenberg, 2003), therefore we also assayed for
VEGF expression. Alpl−/− primary chondrocytes expressed
lower levels of VEGF mRNA than Alpl+/+ cells at all time
points of differentiation and appeared to plateau at later
differentiation time points. Immunofluoresecent staining for
VEGF also revealed diminished VEGF expression in cranial base
synchondroses and particularly in hypertrophic chondrocytes.
Together, our data suggests that TNAP is essential for the
later stages of endochondral bone development including the
apoptosis of hypertrophic chondrocytes and VEGF mediated
recruitment of blood vessels for replacement of cartilage
with bone. How TNAP mediates these effects is not yet
known.
Of relevance to mechanisms that might underlie the
influence of TNAP on growth plate chondrocytes, hypertrophic
zone expansion with diminished endochondral bone growth
is also seen in genetic and diet induced mouse models of
hypophosphatemia. Vitamin D receptor null mice have
expanded and disorganized hypertrophic chondrocyte zones
due to diminished hypertrophic chondrocyte apoptosis that
are rescued upon normalization of calcium and phosphate
levels via diet (Li et al., 1997, 1998; Donohue and Demay,
2002). That this defect in hypertrophic chondrocyte apoptosis
occurs due to low phosphate, as opposed to high calcium
levels, was demonstrated by showing similar growth plate
abnormalities in Phex mutant mice, which have low phosphate
but normal calcium levels (Sabbagh et al., 2005). Subsequent
studies showed that inorganic phosphate induces hypertrophic
chondrocyte apoptosis dependent upon MAPK signaling
(Miedlich et al., 2010). Previous studies also showed that
reduction of MAPK signaling through genetic and chemical
technologies impairs terminal hypertrophic chondrocyte
differentiation and apoptosis (El-Hoss et al., 2014; Chen et al.,
2015). Alpl−/− mice are not hypophosphatemic but TNAP is a
local generator of inorganic phosphate, therefore we next sought
to determine if TNAP deficiency diminishes MAPK signaling.
Immunoprecipitation experiments showed diminished basal
and phosphate induced levels of activated MAPK protein
in Alpl−/− as compared to Alpl+/+ primary rib chondral
cell lysate. Concordantly, immunohistochemical staining
showed diminished phosphorylation of MAPK protein in the
intersphenoidal and sphenoccipital synchondroses of Alpl−/− as
compared to Alpl+/+ mice. Despite similar total levels of MAPK
protein, phosphorylated MAPK protein was essentially absent
from round and columnar chondrocytes, and was diminished in
hypertrophic chondrocytes of Alpl−/− as compared to Alpl+/+
mice at 5 days after birth, prior to the onset of gross phenotypic
abnormalities. These data are consistent with the hypothesis that
growth plate chondrocyte abnormalities in Alpl−/− mice are due
to diminished MAPK signaling, likely due to diminished local
levels of inorganic phosphate. Alpl−/− mice may therefore serve
as an excellent model to distinguish local vs. systemic effects of
phosphate on bone and cartilage. Additional studies are required
to determine if decreased local inorganic phosphate levels and
MAPK signaling are essential to the growth plate chondrocyte
abnormalities seen in Alpl−/− mice.
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shown, including the spheno-occipital (SOS) and inter-sphenoidal (ISS)
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synchondroses. Well demarcated cranial base cortical bone surrounding marrow
and trabecular bone is present in the Alpl+/+ mouse. In contrast, the Alpl−/−
cranial base bones lack distinct cortex, trabeculae and marrow. Additionally, both
the SOS and ISS appear grossly abnormal in the Alpl−/− cranial base, as
compared to that seen in the Alpl+/+ cranial base. 40x magnification of Alpl+/+
SOS (C), Alpl+/+ ISS (D), Alpl−/− SOS (E) and Alpl−/− ISS (F) are shown. Note
increased width of hypertrophic zones in both the SOS and ISS of Alpl−/−
mice.
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